Background
Methods
Outcomes
Predictors
Statistical analysis
Results
Characteristic | n (%) | Characteristic | n (%) |
---|---|---|---|
Age: mean (±SD) | 63.6 years (±14.3) |
Investigations
| |
Gender: female | 16,322 (45.97) | ACR: not monitored | 13,104 (36.91) |
Gender: male | 19,180 (54.03) | ACR: normal | 16,960 (56.00) |
Ethnicity
| ACR: microalbuminuria | 4,623 (13.02) | |
White | 15,222 (42.9) | ACR: macroalbuminuria | 815 (2.30) |
Mixed | 406 (1.1) | HbA1c: not measured | 3,435 (9.7) |
Asian | 6,215 (17.5) | HbA1c: < 7.5% | 19,648 (55.3) |
Black | 2,183 (6.1) | HbA1c: > 7.5% | 12,419 (35.0) |
Other | 2,187 (6.1) | Total cholesterol: not monitored | 2,046 (5.8) |
Not recorded | 9,289 (26.2) | Total cholesterol: < 5.0 mmol/l | 31,553 (88.9) |
Smoking Status
| Total cholesterol: > 5.0 mmol/l | 1,903 (5.4) | |
Not recorded | 7,474 (21.05) | LDL cholesterol: not monitored | 15,678 (44.16) |
Never smoked | 16,349 (46.10) | LDL cholesterol: normal | 14,612 (41.16) |
Current Smoker | 6,620 (18.65) | LDL cholesterol: high | 5,212 (14.68) |
Ex-smoker | 5,059 (14.25) | HDL cholesterol: not monitored | 5,850 (16.48) |
Alcohol Consumption
| HDL cholesterol: normal | 24,372 (68.65) | |
Not recorded | 12,272 (34.57) | HDL cholesterol: low | 5,280 (14.87) |
No alcohol | 11,250 (31.70) |
No Hypertension
| |
Light alcohol | 10,124 (28.52) | Renal function not monitored | 2,200 (6.20) |
Excess alcohol | 1,725 (4.86) | No CKD | 15,229 (42.90) |
Previous excess alcohol | 131 (0.37) | CKD all stages | |
Comorbidities
|
Hypertension
| 569 (1.60) | |
Heart failure | 1,550 (4.37) | Renal function not monitored | 2,260 (6.37) |
Dialysis | 97 (0.27) | No CKD | 5,862 (16.51) |
Stroke | 1,438 (4.05) | CKD stages 1–2 | 7,581 (21.35) |
Transient ischaemic attack | 1,060 (2.99) | CKD stages 3–5 | 3,987 (11.23) |
Ischaemic heart disease | 6,328 (17.82) | CKD stages 3–5 with proteinuria | 3,676 (10.35) |
Coronary artery operation | 2,322 (6.54) | LDL cholesterol: not monitored | 15,678 (44.16) |
Myocardial infarction | 1,895 (5.34) |
Univariate analysis | Multivariate analysis (MLM) | |||
---|---|---|---|---|
Characteristic: | Odds ratio (95% CI) | P = | Odds ratio (95% CI) | P = |
Age (years) | 1.06 (1.06-1.06) | <0.001 | 1.05 (1.05-1.05) | <0.001 |
Gender: female | 1.00 (reference) | - | 1.00 (reference) | - |
Gender: male | 1.21 (1.13-1.31) | <0.001 | 1.24 (1.14-1.36) | <0.001 |
Ethnicity | ||||
White | 1.00 (reference) | - | - | - |
Mixed | 0.61 (0.41-0.92) | 0.019 | - | - |
Asian | 1.00 (0.99-1.01) | 0.488 | - | - |
Black | 0.98 (0.97-1.00) | 0.016 | - | - |
Other | 0.95 (0.80-1.13) | 0.591 | - | - |
Missing | 1.02 (0.94-1.11) | 0.640 | - | - |
Smoking Status | ||||
Not recorded | 1.18 (1.07-1.31) | 0.002 | 0.95 (0.84-1.08) | 0.472 |
Never smoked | 1.00 (reference) | - | 1.00 (reference) | - |
Current Smoker | 1.39 (1.24-1.57) | <0.001 | 1.38 (1.24-1.54) | <0.001 |
Ex-smoker | 1.82 (1.61-2.06) | <0.001 | 1.18 (1.05-1.32) | 0.005 |
Alcohol Consumption | ||||
Not recorded | 0.93 (0.85-1.01) | 0.090 | 1.07 (0.96-1.20) | 0.223 |
No alcohol | 1.00 (reference) | - | 1.00 (reference) | - |
Light alcohol | 0.87 (0.79-0.96) | 0.004 | 0.88 (0.79-0.97) | 0.013 |
Excess alcohol | 1.04 (0.87-1.23) | 0.688 | 1.24 (1.03-1.49) | 0.024 |
Previous excess alcohol | 1.16 (0.66-2.02) | 0.610 | 1.04 (0.56-1.93) | 0.895 |
Comorbidities | ||||
BMI (kg/m2) | 1.01 (0.99-1.02) | 0.276 | - | - |
Heart failure | 3.39 (2.99-3.83) | <0.001 | 1.30 (1.13-1.49) | <0.001 |
Dialysis | 3.03 (1.88-4.89) | <0.001 | 1.76 (1.04-2.99) | 0.036 |
Stroke | 3.96 (3.49-4.48) | <0.001 | 2.26 (1.98-2.59) | <0.001 |
Transient ischaemic attack | 3.27 (2.82-3.79) | <0.001 | 1.58 (1.34-1.86) | <0.001 |
Ischaemic heart disease | 3.03 (2.80-3.27) | <0.001 | 1.64 (1.47-1.84) | <0.001 |
Coronary artery operation | 2.63 (2.35-2.94) | <0.001 | 1.26 (1.09-1.44) | 0.001 |
Myocardial infarction | 2.88 (2.56-3.24) | <0.001 | 1.23 (1.06-1.42) | 0.005 |
Investigations | ||||
ACR: not monitored | 0.77 (0.71-0.84) | <0.001 | 1.33 (1.19-1.50) | <0.001 |
ACR: normal | 1.00 (reference) | - | 1.00 (reference) | - |
ACR: microalbuminuria | 1.46 (1.31-1.62) | <0.001 | 1.16 (1.01-1.32) | 0.034 |
ACR: macroalbuminuria | 2.70 (2.26-3.23) | <0.001 | 2.32 (1.88-2.86) | <0.001 |
HbA1c: not measured | 0.99 (0.98-1.01) | 0.226 | - | - |
HbA1c: < 7.5% | 1.00 (reference) | - | - | - |
HbA1c: > 7.5% | 1.16 (1.01-1.33) | 0.224 | - | - |
Total cholesterol: not monitored | 0.89 (0.76-1.05) | 0.160 | - | - |
Total cholesterol: < 5.0 mmol/l | 1.00 (reference) | - | - | - |
Total cholesterol: > 5.0 mmol/l | 0.88 (0.74-1.04) | 0.134 | - | - |
LDL cholesterol: not monitored | 1.13 (1.05-1.22) | 0.002 | 1.23 (1.08-1.40) | 0.002 |
LDL cholesterol: normal | 1.00 (reference) | - | 1.00 (reference) | - |
LDL cholesterol: high | 0.85 (0.75-0.96) | 0.007 | 1.15 (1.01-1.31) | 0.030 |
HDL cholesterol: not monitored | 1.09 (0.98-1.20) | 0.106 | 1.19 (1.02-1.39) | 0.025 |
HDL cholesterol: normal | 1.00 (reference) | - | 1.00 (reference) | - |
HDL cholesterol: low | 1.13 (1.02-1.25) | 0.022 | 1.17 (1.05-1.31) | 0.006 |
Multilevel model performance:
|
Random effects:
| |||
Bayesian information criteria (BIC) | 19022 | Intercepts for GP practice: | ||
Log-likelihood | -9312 | Variance | 0.111 | |
ROC curve statistic | 0.767 | Standard deviation | 0.334 |
Univariate analysis | Multivariate analysis (MLM) | |||
---|---|---|---|---|
Odds ratio (95% CI) | P = | Odds ratio (95% CI) | P = | |
No Hypertension | ||||
Renal function not monitored | 1.21 (1.00-1.47) | 0.053 | 1.32 (1.07-1.64) | 0.011 |
No CKD | 1.00 (reference) | 1.00 (reference) | - | |
CKD all stages | 3.86 (2.15-6.94) | <0.001 | 1.34 (0.93-1.92) | 0.117 |
Hypertension | ||||
Renal function not monitored | 2.07 (1.76-2.43) | <0.001 | 1.35 (1.13-1.63) | 0.001 |
No CKD | 1.16 (1.01-1.33) | 0.038 | 0.97 (0.84-1.11) | 0.629 |
CKD stages 1–2 | 1.66 (1.48-1.88) | <0.001 | 1.19 (1.03-1.36) | 0.015 |
CKD stages 3–5 | 2.39 (2.10-2.73) | <0.001 | 1.13 (0.98-1.31) | 0.090 |
CKD stages 3–5 with proteinuria | 4.38 (3.88-4.94) | <0.001 | 1.58 (1.36-1.83) | <0.001 |
Hazard ratio (95% CI) | P = | |
---|---|---|
No Hypertension | ||
Renal function not monitored | 1.49 (1.23-1.80) | 0.011 |
No CKD | 1.00 (reference) | - |
CKD all stages | 1.62 (0.76-3.42) | 0.060 |
Hypertension | ||
Renal function not monitored | 1.55 (1.32-1.82) | <0.001 |
No CKD | 0.98 (0.85-1.12) | 0.765 |
CKD stages 1–2 | 1.31 (1.16-1.47) | <0.001 |
CKD stages 3–5 | 1.14 (1.00-1.31) | 0.050 |
CKD stages 3–5 with proteinuria | 1.72 (1.52-1.95) | <0.001 |
Renal function not monitored (N = 4460) n (%) | Renal function monitored (N = 31042) n (%) | P = | |
---|---|---|---|
Age: mean (±SD) | 59.1 years (±16.5) | 64.2 years (±13.9) | <0.001 |
Gender: male | 2,434 (54.6%) | 16,764 (53.9%) | 0.432 |
Ethnicity | N = 2,227 | N = 23,986 | |
White | 1,232 (55.3) | 13,990 (58.3) | |
Mixed | 37 (1.7) | 369 (1.5) | |
Asian | 480 (21.6) | 5,735 (23.9) | |
Black | 210 (9.4) | 1,973 (8.2) | |
Other | 268 (12.0) | 1,919 (8.0) | <0.001 |
Smoking Status | N = 2765 | N = 25263 | |
Never smoked | 1,562 (56.5) | 14,787 (58.5) | |
Current Smoker | 741 (26.8) | 5,879 (18.2) | |
Ex-smoker | 462 (16.7) | 4,597 (18.2) | <0.001 |
Alcohol Consumption | N = 1,662 | N = 21568 | |
No alcohol | 736 (44.3) | 10,514 (48.7) | |
Light alcohol | 707 (42.5) | 9,417 (43.7) | |
Excess alcohol | 194 (11.7) | 1,531 (7.1) | |
Previous excess alcohol | 25 (1.5) | 106 (0.5) | <0.001 |
Investigations | |||
HbA1c: not monitored | 1,496 (33.5) | 1,939 (6.2) | <0.001 |
HbA1c: mean (±SD) | 8.16% (±2.09) | 8.55 (±2.07) | <0.001 |
Total cholesterol: not monitored | 1,413 (31.7) | 633 (2.0) | <0.001 |
Total cholesterol: mean (±SD) | 4.93 mmol/l (±1.15) | 4.60 mmol/l (±1.08) | <0.001 |
LDL cholesterol: not monitored | 2,510 (56.3) | 13,168 (42.4) | <0.001 |
LDL cholesterol: mean (±SD) | 2.70 mmol/l (±0.99) | 2.51 mmol/l (±0.91) | <0.001 |
HDL cholesterol: not monitored | 1,688 (37.8) | 4,162 (13.4) | <0.001 |
HDL cholesterol: mean (±SD) | 1.35 mmol/l (±0.39) | 1.29 mmol/l (±0.38) | <0.001 |
Medications | |||
ACE/ARBs prescribed | 1,847 (41.4) | 20,403 (65.7) | <0.001 |
Lipid lowering drugs prescribed | 2,134 (47.8) | 24,136 (77.8) | <0.001 |
Aspirin prescribed | 801 (18.0) | 9,081 (29.3) | <0.001 |